MACROGENICS INC

MGNX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 293 employees
227
SEC Filings
$3.97
Close 2026-09-10
293
Employees

Business Summary

MacroGenics is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for cancer treatment. It generates product candidates from proprietary platforms including DART and TRIDENT bispecific antibodies and antibody-drug conjugates (ADCs). Key pipeline assets include lorigerlimab, MGC026, and MGC028. The company also operates a commercial-scale cGMP antibody manufacturing facility and provides contract development and manufacturing services. Three partnered products—ZYNYZ, MARGENZA, and TZIELD—have received FDA approval.

Latest Stock Quote

MGNX 2026-09-10 $3.97 O:$4.08 H:$4.115 L:$3.9 Vol:0.4M VWAP:$3.9881
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001125345-26-000017EDGAR72K words
2025-03-202024-12-310001125345-25-000042EDGAR73K words
2024-03-072023-12-310001125345-24-000060EDGAR76K words
2023-03-152022-12-310001125345-23-000059EDGAR—
2022-02-242021-12-310001125345-22-000013EDGAR—
2021-02-252020-12-310001125345-21-000035EDGAR—
2020-02-252019-12-310001125345-20-000031EDGAR—
2019-02-262018-12-310001125345-19-000046EDGAR—
2018-02-272017-12-310001125345-18-000022EDGAR—
2017-02-282016-12-310001125345-17-000041EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001125345-26-000056EDGAR22K words
2025-11-122025-09-300001125345-25-000108EDGAR17K words
2025-08-142025-06-300001125345-25-000101EDGAR15K words
2025-05-132025-03-310001125345-25-000053EDGAR14K words
2024-11-052024-09-300001125345-24-000160EDGAR16K words
2024-08-062024-06-300001125345-24-000148EDGAR15K words
2024-05-092024-03-310001125345-24-000088EDGAR13K words
2023-11-062023-09-300001125345-23-000124EDGAR22K words
2023-08-092023-06-300001125345-23-000108EDGAR22K words
2023-05-092023-03-310001125345-23-000076EDGAR—
2022-11-032022-09-300001125345-22-000104EDGAR—
2022-08-082022-06-300001125345-22-000090EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001125345-26-000054EDGAR3K words
2026-07-230001125345-26-000050EDGAR1K words
2026-03-090001125345-26-000018EDGAR2K words
2026-03-020001125345-26-000011EDGAR1K words
2026-02-240001125345-26-000009EDGAR1K words
2025-11-200001125345-25-000111EDGAR1K words
2025-11-120001125345-25-000109EDGAR3K words
2025-08-140001125345-25-000100EDGAR3K words
2025-08-130001125345-25-000094EDGAR1K words
2025-06-100001125345-25-000087EDGAR1K words

227 total filings indexed. 195 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology hematologic-malignancies type-1-diabetes contract-development-and-manufacturing-services dart-(bispecific-antibody-platform) trident-(multi-specific-antibody-platform) glycoconnect-conjugation-technology cgmp-antibody-manufacturing

Company Identity

CIK0001125345
TickerMGNX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.macrogenics.com
Listed2013-10-10

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: f65b1bfa1c6b25e6b7750a4def5b836575f83f7129ef6d8deb7b4be317269711
parent: 01054a2aab9d7c130a9c1c7694315685c91c43e27f85bbab51118a64ef49d3d0
content hash: cfa796839f27ad7e07e53e4f15c4249cb53a29e6f5ce7e302859fb7dc91c6e01
signed: 2026-09-28T19:02:10.365Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up MGNX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on MGNX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/MGNX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.